An Indian diagnostics chain and a university research centre will train and validate radiology AI on Indian patient data, then…
The Oxford spinout and the Pulmonary Fibrosis Foundation will study how people…
The New York startup automates rule-reading for Medicaid plans and other payers…
A Kansas City startup wants to fold banking, billing and procurement into…
Zeta Surgical launched a DARPA collaboration to advance robotic, neuronavigated single-day transcranial…
Drug-safety monitoring has a blind spot, and a team at the University…
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
A virtual-cell model trained on 38 million protein measurements matched real treatment…
A pathology AI trained only on frozen sections matched real surgical decisions…
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
MaxQ Medical banks $31.5M from Olympus and others for a transurethral ultrasound and therapy platform.
The Australian biotech will use Amazon's cloud and AI tools across discovery and clinical development,…
Oracle Health's Clinical AI Agent adds automated billing, dictation, and chart review in the US.
The orchestration layer decides which scanner series belong to which algorithm, before a study finishes.
A government lab is testing personalized videos as a new form of dementia therapy.
Columbia University Irving Medical Center and AWS have launched a collaboration to build and commercialize…
A Management Science study found a human-plus-algorithm review model could cut device review workload and…
NMPA clears Westlake's Mprosevir, China's first AI-assisted Class 1 drug.